-
1
المؤلفون: Felix Steger, Anke Schlenska-Lange, Marlitt Horn, M. Faehling, Jürgen Alt, Stephan Eisenmann, Wolfgang M. Brückl, Daniel C. Christoph, Petra Hoffknecht, Christian Schumann, Petros Christopoulos, Philipp Schütt
المصدر: Lung Cancer. 150:114-122
مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Durvalumab, Population, Locally advanced, non-small cell lung cancer (NSCLC), 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, education, Adverse effect, education.field_of_study, business.industry, Antibodies, Monoclonal, Chemoradiotherapy, Definitive chemoradiotherapy, medicine.disease, 030104 developmental biology, 030220 oncology & carcinogenesis, Expanded access, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef66eca88e3a561eb53d42359b372b12Test
https://doi.org/10.1016/j.lungcan.2020.10.006Test -
2
المؤلفون: Linda Diehl, Balázs Jóri, Petra Hoffknecht, H. Ramdani, Len Kaller, Frank Griesinger, S. Schatz, Lukas C. Heukamp, Bettina Kah, Christian Grohé, Markus Tiemann, Markus Falk, J. Roeper
المصدر: Cancers
Volume 13
Issue 12
Cancers, Vol 13, Iss 2861, p 2861 (2021)مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_treatment, Article, 03 medical and health sciences, 0302 clinical medicine, Second line, Tki resistance, Medicine, Osimertinib, Liquid biopsy, Lung cancer, osimertinib resistance, RC254-282, liquid biopsy, business.industry, Hybrid capture, Disease progression, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, routine diagnostics, respiratory tract diseases, lung cancer, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cancer research, business, Adjuvant
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b652b9684fd65dc190c6bb81d2a1f57eTest
-
3
المؤلفون: Stephanie Dille, A. Fleitz, Jacqueline Rauh, Lukas C. Heukamp, Marlen Sandberg, Tobias Dechow, Albrecht Stenzinger, Frank Griesinger, Mike Thomas, Konrad Kokowski, Matthias Groschek, Wilko Weichert, Wolfgang Schütte, Wilfried Eberhardt, Jürgen Alt, Reinhard Büttner, Stefan Zacharias, Martin Sebastian, Martina Jänicke, Eyck von der Heyde, Thomas Wehler, A. Hipper, Petra Hoffknecht, Martin Metzenmacher
مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Medizin, medicine.disease_cause, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Germany, Medicine, Humans, Prospective Studies, Registries, Lung cancer, neoplasms, business.industry, Standard treatment, medicine.disease, ddc, respiratory tract diseases, 030104 developmental biology, 030220 oncology & carcinogenesis, Trk receptor, Cohort, Mutation, Population study, Observational study, KRAS, business, Cohort study
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99033094ddf7a1abf8a1507bdf20369eTest
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85100908806Test -
4
المؤلفون: Lukas C. Heukamp, Balázs Jóri, S. Schatz, Eva-Maria Willing, Matthias Kröger, Harry J.M. Groen, Linda Diehl, Stefanie Schmidt, Markus Falk, Hayat Oum El Kheir Ramdani, Frank Griesinger, Markus Tiemann, C. Wesseler, Roopika Menon, Petra Hoffknecht
المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Cancers, 12(6):1685, 1-14. MDPI AG
Cancers
Volume 12
Issue 6
Cancers, Vol 12, Iss 1685, p 1685 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, PD-L1, Cancer Research, medicine.medical_specialty, tumor mutational burden, BLOCKADE, NEOANTIGENS, PHASE-1, medicine.disease_cause, lcsh:RC254-282, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, IMMUNOHISTOCHEMISTRY, Lung cancer, immuno-oncology, Mutation, biology, business.industry, driver mutation, Routine laboratory, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, routine diagnostics, OPEN-LABEL, EFFICACY, Immune checkpoint, respiratory tract diseases, lung cancer, 1ST-LINE TREATMENT, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, NIVOLUMAB PLUS IPILIMUMAB, Biomarker (medicine), Non small cell, Antibody, SENSITIVITY, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c8ac4497f7a0a8ca98d267c72164bc1Test
https://research.rug.nl/en/publications/3f08a1fc-fe7c-4f77-9a0f-80bf8ce9b9c8Test